Compare Tenet Healthcare Corporation (THC) vs Victoria's Secret & Co (VSXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tenet Healthcare Corporation vs Victoria's Secret & Co — how do they compare? Tenet Healthcare Corporation trades at $260 (market cap $20.92B), while Victoria's Secret & Co trades at $87.1 (market cap $6.84B). The key difference: Tenet Healthcare Corporation is far larger — about 3.1× Victoria's Secret & Co's market cap, and Victoria's Secret & Co is more actively traded (774,930.85 versus 455,764). Which is the better fit depends on your goals — on Pluang, investors hold Tenet Healthcare Corporation for 15 Days and Victoria's Secret & Co for 34 Days on average.
| THC | VSXY | |
|---|---|---|
Market Cap | $20.92B | $6.84B |
Volume | 455,764 | 774,930.85 |
Sector | Health | Consumer Cyclical |
52-Week High | $280.77 | $99.97 |
52-Week Low | $161.37 | $28.25 |
Typical Hold Time | 15 Days | 34 Days |
Enterprise Value | $32.00B | $9.22B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Victoria's Secret (VSXY) trades at $86.61, up 1.8% with bullish technical signals and strong earnings momentum after beating Q2 2026 estimates. The company shows improving fundamentals with revenue stabilizing at $6.2B and net income recovering to $165M. Analyst consensus remains positive with 60% buy ratings and a $86.80 price target, while recent news highlights the company's fashion show expansion and global growth initiatives.
The outlook appears favorable with projected 2026 revenue growth to $6.9B and net income of $378M, though elevated valuation metrics (P/E 19.15, P/B 6.91) and competitive retail pressures present risks. The stock offers exposure to a brand turnaround story with improving margins and institutional interest, but requires monitoring of consumer spending trends and execution on growth initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →About Victoria's Secret & Co
Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →
